Metabolic neuropathies

Current Opinion in Neurology

Volumn 11, Issue 5, 1998, Pages 523-529

  Comi, Giancarlo ^a,b   Corbo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN;

AUTONOMIC DYSFUNCTION; CHRONIC LIVER DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE DURATION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; NERVE FUNCTION; NEUROPATHY; PANCREAS TRANSPLANTATION; PATHOGENESIS; PERIPHERAL NEUROPATHY; REVIEW; SMOKING;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0031723238     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199810000-00015     Document Type: Review

References (46)

1. Forrest KY-Z, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy. A prospective study. Diabetes 1997; 46:665-670. This study, which prospectively investigates the risk factors for diabetic polyneuropathy, raises the strong possibility that hypertension may have a major pathogenetic role in developing peripheral nerve damage.
2. Sundkvist G, Lilja B, Nilsson H, Nilsson J-A, Rosen I. Peripheral nerve dysfunction is reflected by loss of ankle reflexes but not by autonomic neuropathy in diabetic patients. Muscle Nerve 1997; 20:740-743.
3. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of iabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997; 49:229-239.1 This is a longitudinal study of almost 200 patients that provides insights about which symptoms, impairments, tests, or composite scores are best used as minimal criteria for diagnosis of diabetic polyneuropathy and as a quantitative measure of its severity.
4. Comi G. The validity of instrumental tests in monitoring interventions in diabetic neuropathy. In: Recent advances in clinical neurophysiology. Kimura J, Shibasaki H (editors). Tokyo: Elsevier Science B.V.; 1996. pp. 798-808.
5. Arezzo JC. The use of electrophysiology for the assessment of diabetic neuropathy. Neurosci Res Commun 1997; 21:13-23.
6. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, et al., and the Italian Diabetic Neuropathy Committee. A multicenter study on the prevalence of diabetic neuropathy in Italy. Diabetes Care 1997; 20:836-843. The prevalence of neuropathy has been determined in the largest group of diabetic patients examined to date. Neuropathy resulted a common complication of diabetes mellitus and was present in almost one-third of all patients.
7. Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 1997; 40:1062-1069.
8. Thomas PK. Clinical features and investigation of diabetic somatic peripheral neuropathy. Clin Neurosci 1997; 4:341-345.
9. Katoulis EC, Ebdon-Parry M, Hollis S, Harrison AJ, Vileikyte L, Kulkarni J, Boulton AJM. Postural instability in diabetic neuropathic patients at risk of foot ulceration. Diabetic Med 1997; 14:296-300.
10. Cacciatori V, Dellera A, Bellavere F, Bongiovanni LG, Teatini F, Gemma ML, Muggeo M. Comparative assessment of peripheral sympathetic function by postural vasoconstriction arteriolar reflex and sympathetic skin response in NIDDM patients. Am J Med 1997; 102:365-370.
11. Bellavere F, Bosello G, Cardone C, Girardello L, Ferri M, Fedele D. Evidence of early impairment of parasympathetic reflexes in insulin dependent diabetics without autonomic symptoms. Diabete Metab 1985; 11:142: 152-156.
12. Wieling W, Smit AAJ, Karemaker JM. Diabetic autonomic neuropathy: conventional cardiovascular laboratory testing and new developments. Neurosci Res Commun 1997; 21:67-74.
13. Spallone V, Maiello MR, Cicconetti E, Menzinger G. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract 1997; 34:169-179.
14. Feldman EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997; 4:365-370.
15. Mizisin AP, Li L, Calcutt NA. Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma cells. Neurosci Lett 1997; 229:53-56.
16. Mizisin AP, Powell HC. Schwann cell changes induced as early as one week after galactose intoxication. Acta Neuropathol 1997; 93:611-618.
17. Van Dam PS, Bravenboer B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun 1997; 21:41-48.
18. Roberts RE, McLean WG. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res 1997; 754:147-156.
19. Ryle C, Leow CK, Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 1997; 20:577-584.
20. Engelstad JK, Davies JL, Giannini C, O'Brien PC, Dyck PJ. No evidence for axonal atrophy in human diabetic polyneuropathy. J Neuropathol Exp Neurol 1997; 56:255-262. An accurate morphometric analysis of sural nerve specimens from diabetic patients, which does not support the hypothesis that axonal atrophy occurs in human diabetic polyneuropathy.
21. Pitei DL, Watkins PJ, Edmonds ME. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabetic Med 1997; 14:284-290.
22. Theriault M, Dort J, Sutherland G, Zochodne DW. Local human sural nerve blood flow in diabetic and other polyneuropathies. Brain 1997; 120:1131-1138.
23. Scarpini E, Conti G, Chianese L, Baron PL, Pizzul S, Basellini A, et al. Induction of p75NGFR in human diabetic neuropathy. J Neuol Sci 1996; 135:55-62.
24. Conti G, Stoll G, Scarpini E, Baron PL, Bianchi R, Livraghi S, Scarlato G. p75 neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: possible relevance on regeneration. Exp Neurol 1997; 146:206-211.
25. Sima AAF, Cherian PV. Neuropathology of diabetic neuropathy and its correlations with neurophysiology. Clin Neurosci 1997; 4:359-364.
26. Canal N, Nemni R. Autoimmunity and diabetic neuropathy. Clin Neurosci 1997; 4:371-373.
27. Cachia MJ, Peakman M, Zanone M, Watkins PJ, Vergani D. Reproducibil ity and persistence of neural and adrenal autoantibodies in diabetic autonomic neuropathy. Diabetic Med 1997; 14:461-465. The report demonstrates the persistence of complement-fixing autoantibodies to autonomic nervous system over a period of up to 2.7 years in a group of IDDM patients with autonomic neuropathy.
28. Muhr D, Mollenhauer U, Ziegler A-G, Haslbeck M, Standl E, Schnell O. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care 1997; 20:1009-1012.
29. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122:561-568.
30. Low PA, Yao JK, Kishi Y, Tritschler HJ, Schmelzer JD, Zollman PJ, Nickander KK. Peripheral nerve energy metabolism in experimental diabetic neuropathy. Neurosci Res Commun 1997; 21:49-56.
31. Sima AF, Green DA, Brown MB, Hohman TC, Hicks D, Graepel GJ, et al. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemisty and morphometry in advanced diabetic peripheral polyneuropathy. J Diab Compl 1993; 7:157-169.
32. Daniele E, Coco MP. Tolrestate in the therapy of diabetic peripheral neuropathy: is this drug really useful? Clin Ther 1995; 146:793-799.
33. Ito T, Nishimura C, Takahashi Y, Salto T, Omori Y. The level of erythrocyle aldose reductase: a risk factor for diabetic neuropathy? Diabetes Res Clin Pract 1997; 36:161-167.
34. Allen RDM, Al-Harbi IS, Morris JGL, Clouston PD, O'Connell PJ, Chapman JR, Nankivell BJ. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997; 63:830-838. This paper demonstrates the recovery of peripheral neuropathy for up to 8 years after simultaneous pancreas and kidney transplantation in uraemic diabetic patients.
35. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to glycaemic control provided by the pancreas. Diabetologia 1997; 40:1110-1112.
36. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and post-herpetic neuralgia. Neurology 1997; 48:1212-1218.
37. Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM. Evidence for a selective defect. Diabetes 1997; 46:814-823.
38. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, et al. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy. Effects on hypoglycemia awareness and counterregulation. Diabetes 1997; 46:1172-1181.
39. Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJ. Gustatory sweating in diabetes mellitus. Diabetic Med 1996; 13:1033-1037.
40. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJ. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 1997; 40:299-301.
41. Pozzessere G, Valle E, D'Alessio C, Soldati G, Pierelli F, Leonetti F, et al. Effects of spontaneous chronic hypoglycemia on central and peripheral nervous system in insulinoma patients before and after surgery: a neurophysiological follow-up. J Clin Endocrinol Metab 1997; 82:1447-1451.
42. Pirzada NA, Morgenlander JC. Peripheral neuropathy in patients with chronic renal failure. A treatable source of discomfort and disability. Postgrad Med 1997; 102:249-261.
43. Mendoza-Guevara L, Cervantes A, Aguilar-Kitsu A, Rendon E, Rodriguez F, Castro F, et al. 'H' reflex as a measure of subclinical uremic polyneuropathy in children with chronic renal failure. Adv Periton Dial 1997; 13:285-290.
44. Oliver MI, Miralles R, Rubies-Prat J, Navarro X, Espadaler JM, Sola R, Andreu M. Autonomic dysfunction in patients with non-alcoholic chronic liver disease. J Hepatol 1997; 26:1242-1248. A high prevalence of abnormalities in autonomic function tests, with a poor relationship with liver function parameters, are found in patients with nonalcoholic chronic liver disease.
45. Voigt MD, Trey G, Levitt NS, Raine R, Lombard CJ, Robson SC, et al. Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc. J Hepatol 1997; 26:634-641.
46. Lai CL, Tai CT, Liu CK, Lin RT, Howng SL. A longitudinal study of central and peripheral nerve conduction in hypothyroid rats. J Neurol Sci 1997; 148:139-145.